Yazar "Buyukasik, Yahya" için listeleme
-
Changes in vascular endothelial growth factor, angiopoietins, and Tie-2 levels with G-CSF stimulation in healthy donors
Serefhanoglu, Songul; Goker, Hakan; Buyukasik, Yahya; Turgut, Mehmet; Sayinalp, Nilgun; Haznedaroglu, Ibrahim Celalettin; Ozcebe, Osman Ilhami (Springer, 2009)The roles of vascular endothelial growth factor (VEGF), Tie-2, and angiopoietins in the mobilization of the hematopoietic stem cells (HSCs) in humans are not yet clearly understood. In order to elucidate mechanisms of HSC ... -
Clinical features and outcomes of 49 Turkish patients with acute promyelocytic leukemia who received ATRA and anthracyclines (PETHEMA protocol) therapy
Serefhanoglu, Songul; Buyukasik, Yahya; Goker, Hakan; Sayinalp, Nilgun; Haznedaroglu, Ibrahim Celalettin; Aksu, Salih; Ozdemir, Evren (Pergamon-Elsevier Science Ltd, 2010)… -
Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic hematopoietic stem cell transplantation for acute leukemia patients: A single center experience
Goker, Hakan; Ozdemir, Evren; Uz, Burak; Buyukasik, Yahya; Turgut, Mehmet; Serefhanoglu, Songul; Ozcebe, Osman I. (Pergamon-Elsevier Science Ltd, 2013)Due to the high transplant related morbidity and mortality (TRM), relatively younger acute leukemia patients that have a good performance status and no comorbidity are eligible for myeloablative conditioning (MAC) followed ... -
EUTOS CML prognostic scoring system predicts ELN-based 'event-free survival' better than Euro/Hasford and Sokal systems in CML patients receiving front-line imatinib mesylate
Uz, Burak; Buyukasik, Yahya; Atay, Hilmi; Kelkitli, Engin; Turgut, Mehmet; Bektas, Ozlen; Haznedaroglu, Ibrahim C. (Taylor & Francis Ltd, 2013)Objectives: The validity of the three currently used chronic myeloid leukemia (CML) scoring systems (Sokal CML prognostic scoring system, Euro/Hasford CML scoring system, and the EUTOS CML prognostic scoring system) were ... -
Generic Imatinib Mesylate is as Effective as Original Glivec in the Clinical Management of CML
Malkan, Umit Y.; Aksu, Salih; Aktimur, Sude H.; Atay, Hilmi; Bektas, Ozlen; Buyukasik, Yahya; Haznedaroglu, Ibrahim C. (Akad Doktorlar Yayinevi, 2015)Unsustainable drug prices in chronic myeloid leukemia (CML) and cancer may be causing harm to patients. The aim of this multi-center study is to assess the efficacy of generic imatinib mesylate (IM) over Glivec in terms ... -
Hematopoietic stem cell transplantation in geriatric patients in Turkey
Goker, Hakan; Kelkitli, Engin; Buyukasik, Yahya; Demiroglu, Haluk (Pergamon-Elsevier Science Ltd, 2018)The incidence of most hematologic malignancies increases with age. Physicians increasingly refer older patients for hematopoietic stem cell transplantation (HSCT) due to more experience and improved supportive care in HSCT. ... -
Hyper-CVAD Regimen in Routine Management of Adult Acute Lymphoblastic Leukemia: A Retrospective Multicenter Study
Buyukasik, Yahya; Acar, Kadir; Kelkitli, Engin; Uz, Burak; Serefhanoglu, Songul; Ozdemir, Evren; Haznedaroglu, Ibrahim C. (Karger, 2013)Treatment of acute lymphoblastic leukemia is unsatisfactory in adults due to disease and patient-related factors and probably because adult chemotherapy regimens are weaker than pediatric protocols. Worries about inadequacy ... -
Mantle cell lymphoma: a Turkish Multi-Center Study
Okay, Mufide; Meletli, Ozgur; Kelkitli, Engin; Malkan, Umit Yavuz; Turgut, Mehmet; Buyukasik, Yahya; Goker, Hakan (Imprimatur Publications, 2019)Purpose: Mantle Cell Lymphoma (MCL) is a B-cell neoplasm with CCND1 [t(11;14)(q13;q32), cyclin D1] translocation. The guidelines recommend various treatment options based on age, performance status and comorbidities. Our ... -
Polycythemia vera: diagnosis, clinical course, and current management
Buyukasik, Yahya; Ali, Ridvan; Cem, A. R.; Turgut, Mehmet; Yavuz, Selim; Saydam, Guray (Tubitak Scientific & Technical Research Council Turkey, 2018)Very important developments related to polycythemia vera (PV) have occurred during the last two decades. The discovery of Janus kinase (JAK) 2 mutations has changed both the diagnosis and clinical management of PV. Currently ... -
Predictive factors for stem cell mobilization failure in multiple myeloma patients: A single center experience
Goker, Hakan; Ciftciler, Rafiye; Demiroglu, Haluk; Turgut, Mehmet; Sayinalp, Nilgun; Haznedaroglu, I. C.; Buyukasik, Yahya (Pergamon-Elsevier Science Ltd, 2020)Background and aim: High-dose chemotherapy followed by autologous stem cell transplantation (ASCT) has been considered the standard of treatment care for patients with multiple myeloma (MM). Insufficient mobilization and ...
